𝔖 Bobbio Scriptorium
✦   LIBER   ✦

On the prediction of the histologic composition of benign prostatic hyperplasia based on clinical and MRI parameters

✍ Scribed by Weijers, René E.; Zambon, Jan-Victor; Kessels, Alfons G.H.; de Bruïne, Adriaan P.

Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
456 KB
Volume
32
Category
Article
ISSN
0270-4137

No coin nor oath required. For personal study only.

✦ Synopsis

Background:

The histologic composition of prostate adenoma seems related to the development of clinical benign prostatic hyperplasia (bph). therefore, a new noninvasive prediction model as an alternative for biopsies was investigated.

Methods:

In 19 patients, the data of a routine preoperative workup for transurethral resection (turp) and of an additional mri-examination were related to the results of morphometry on turp-tissue.

Results:

Statistical analysis identified age of the patient and mri-volumetrics of the prostate adenoma as best predictors of the epithelial fraction, with a 95% confidence interval of at least 5% (range, 9-14%) (r2 = 50%).

Conclusions:

This prediction model is sufficiently accurate to categorize a population of patients into histologic subgroups. it seems very likely that this method will be of use as an investigative tool in medical trials to provide insight into the pathogenesis of clinical bph and into treatment strategies for the individual patient.

📜 SIMILAR VOLUMES

The influence of prostate volume on the
The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia
✍ Carsten Stephan; Michael Lein; Klaus Jung; Dietmar Schnorr; Stefan A. Loening 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

T1, 2, 3pN0, M0), 44 patients with BPH, and 54 healthy Charite ´, Humboldt University Berlin, Berlin, Gercontrols. Prostate volume was determined by transrectal ultrasound. many. ## RESULTS. The median values of t-PSA and f-PSA% were 7.8 mg/L and 10.5% in PCa patients, 4.3 mg/L and 20.8% in patie

Effects of long-term treatment withSeren
Effects of long-term treatment withSerenoa repens (Permixon®) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia
✍ Di Silverio, F.; Monti, S.; Sciarra, A.; Varasano, P.A.; Martini, C.; Lanzara, S 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB 👁 2 views

## Background: The n-hexane lipido-sterol extract of serenoa repens (lsesr, permixon, pierre fabre medicament, castres, france), a phytotherapeutic agent used in the treatment of benign prostatic hyperplasia (bph), has a multisite mechanism of action including inhibition of types 1 and 2 5alpha-red

Comment on “Value of the Danish prostate
Comment on “Value of the Danish prostate symptom score compared to the AUA symptom score and pressure/flow studies in the preoperative evaluation of men with symptomatic benign hyperplasia,” Neurourol Urodynam (1998):17:9–18
✍ Jesper Schou; Tage Hald; Jørgen Nordling 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 8 KB 👁 1 views

One of the conclusions of this paper is that the Danish Prostatic Symptom score is a valid and sensitive questionnaire for the assessment of LUTS. We fully agree and recommend this questionnaire instead of the IPSS score, because it is more sensitive to changes after treatment/intervention [Flyger e